Therefore, it is indicated that RA patients with higher ATF3 expression in the synovium seemed to have higher contents of activated mast cells and more serious disease conditions, but they might respond better when receiving the treatment of tocilizumab or methotrexate. Here, ATF3 is linked to rheumatoid arthritis.